Filter by
Filter by
Proton therapy for intracranial meningioma: a single-institution retrospective analysis of efficacy, survival and toxicity outcomes.
This review included 57 papers reporting patient outcomes related to PT treatment of CNS/skull base tumors in adults. The treatment results of PT for gliomas...
Possible association of dose rate and the development of late visual toxicity for patients with intracranial tumours treated with pencil beam scanned proton therapy.
This study reported two unusual optic nerve toxicities (CTCAE grade 3 and 4) in patients with meningioma treated with IMPT. For these two unexplained toxicity...
Proton versus photon adjuvant radiotherapy: a multicenter comparative evaluation of recurrence following spinal chordoma resection.
This study by the Mayo Clinic group compared recurrence in patients with chordomas who received proton versus photon radiotherapy following resection, by using...
Optimizing radiotherapy strategies for skull base chordoma: a comprehensive meta-analysis and systematic review of treatment modalities and outcomes.
This meta-analysis from Brazil included 32 studies that reported outcomes of different radiation modalities for skull base chordoma. The 5-year OS findings were...
Patient reported fatigue after proton therapy for malignant brain tumours - Is there a relation between radiation dose and brain structures?
This study by the Skandion Clinic group reported patient-reported fatigue and quality of life of 167 adults who received PBT for malignant brain tumors. No...
Brain volume loss after cranial irradiation: a controlled comparison study between photon vs proton radiotherapy for WHO grade 2-3 gliomas.
This study from the MGH group analyzed brain volume change in two matched groups of patients with WHO grade 2-3 gliomas treated with either PRT (n = 17) or XRT...
Short-course hypofractionated proton beam therapy, incorporating 18F-DOPA PET and contrast-enhanced MRI targeting, for patients aged 65 years and older with newly diagnosed glioblastoma: a single-arm phase 2 trial.
Published in the Lancet Oncology, this study from the Mayo Clinic group reported outcomes of 39 patients with WHO grade 4 glioblastoma treated with concurrent...